Data from a late-breaking abstract presented at the International Liver Congress 2014 identifies a new compound, SBEL1, that has the ability to inhibit hepatitis C virus (HCV) activity in cells at several points in the virus' ...
Apr 12, 2014
0
0
Chronic hepatitis B infections represent a global health problem that could hitherto only be treated by chemotherapy. A team of researchers led by Rudolf Valenta from MedUni Vienna's Center for Pathophysiology, Infectiology ...
Aug 26, 2020
0
7
New research sheds light on how a hepatitis B viral protein stimulates the expansion of immune cells that impair antiviral responses, according to a study published April 18 in the open-access journal PLOS Pathogens by Haitao ...
Apr 18, 2019
0
62
New data presented today at The International Liver Congress 2016 in Barcelona, Spain, demonstrates a high sustained virologic response (SVR) at 12 weeks from the all-oral combination of sofosbuvir/velpatasvir and experimental ...
Apr 14, 2016
0
10
NIH investigators and colleagues have discovered that when the immune system first responds to infectious agents such as viruses or bacteria, a natural brake on the response prevents overactivation. Their new study in mBio ...
Jun 23, 2020
0
3
There's new hope for patients with liver disease who are waiting for a donor liver to become available for transplantation.
Dec 14, 2016
0
2
Arthur Conan Doyle's famous literary detective Sherlock Holmes once noted that "the little things are infinitely the most important." It's a belief that investigators at the University of Alberta obviously share. Whether ...
Mar 24, 2016
2
17
In severe cases, a viral hepatitis infection can result in liver failure. A team from the Technical University of Munich (TUM) has now discovered that immune cells attack cells in the vascular system, which disrupts the liver's ...
Dec 20, 2018
0
1
The European Association for the Study of the Liver (EASL) today published their revised Clinical Practice Guidelines (CPGs) on the management of Hepatitis B virus (HBV) infection. The CPGs, which will also be presented in ...
Apr 20, 2017
0
1
(HealthDay) -- Universal hepatitis B virus (HBV) screening before chemotherapy for lymphoma reduces costs in most settings, according to a study published online June 18 in the Journal of Clinical Oncology.
Jun 20, 2012
0
0
